Literature DB >> 12964068

Arzoxifene Eli Lilly.

Cristina Marchisano-Karpman1, Micheal W DeGregorio.   

Abstract

Arzoxifene is a benzothiophene second-generation selective estrogen receptor modulator (SERM) under development by Eli Lilly & Co as a potential treatment for cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964068

Source DB:  PubMed          Journal:  IDrugs        ISSN: 1369-7056


  1 in total

1.  Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.

Authors:  Abhishek Sharma; Weiyi Toy; Valeria Sanabria Guillen; Naina Sharma; Jian Min; Kathryn E Carlson; Christopher G Mayne; Shengjia Lin; Michael Sabio; Geoffrey Greene; Benita S Katzenellenbogen; Sarat Chandarlapaty; John A Katzenellenbogen
Journal:  ACS Chem Biol       Date:  2018-11-26       Impact factor: 5.100

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.